JPWO2021187392A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021187392A5 JPWO2021187392A5 JP2022508332A JP2022508332A JPWO2021187392A5 JP WO2021187392 A5 JPWO2021187392 A5 JP WO2021187392A5 JP 2022508332 A JP2022508332 A JP 2022508332A JP 2022508332 A JP2022508332 A JP 2022508332A JP WO2021187392 A5 JPWO2021187392 A5 JP WO2021187392A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- double
- acid strand
- complex according
- stranded nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020045137 | 2020-03-16 | ||
| PCT/JP2021/010214 WO2021187392A1 (ja) | 2020-03-16 | 2021-03-12 | モルホリノ核酸を含むヘテロ核酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021187392A1 JPWO2021187392A1 (https=) | 2021-09-23 |
| JPWO2021187392A5 true JPWO2021187392A5 (https=) | 2024-03-19 |
Family
ID=77771533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022508332A Pending JPWO2021187392A1 (https=) | 2020-03-16 | 2021-03-12 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230174981A1 (https=) |
| EP (1) | EP4123023A4 (https=) |
| JP (1) | JPWO2021187392A1 (https=) |
| WO (1) | WO2021187392A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2024071362A1 (https=) * | 2022-09-30 | 2024-04-04 | ||
| JPWO2024106545A1 (https=) * | 2022-11-18 | 2024-05-23 | ||
| WO2026034445A1 (ja) * | 2024-08-05 | 2026-02-12 | 日本新薬株式会社 | ホスホロジアミデートモルフォリノオリゴ核酸（ｐｍｏ）とポリアニオンとを含む、ｐｍｏ複合体 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060018902A (ko) * | 2003-06-27 | 2006-03-02 | 텔 아비브 유니버시티 퓨쳐 테크놀로지 디벨롭먼트 엘.피. | 글리코겐 신타제 키나제-3 억제제 |
| EP2023940B1 (en) | 2006-05-05 | 2011-06-22 | Isis Pharmaceuticals, Inc. | Compounds and methods for modulating expression of sglt2 |
| ES2603379T3 (es) | 2006-10-09 | 2017-02-27 | Roche Innovation Center Copenhagen A/S | Compuestos antagonistas de ARN para la modulación de PCSK9 |
| WO2008049085A1 (en) | 2006-10-18 | 2008-04-24 | Isis Pharmaceuticals, Inc. | Antisense compounds |
| AU2012353330B2 (en) | 2011-12-16 | 2018-04-19 | National University Corporation Tokyo Medical And Dental University | Chimeric double-stranded nucleic acid |
| ES2700277T3 (es) | 2013-05-30 | 2019-02-14 | Univ Nat Corp Tokyo Medical & Dental | Agentes de doble cadena para el suministro de oligonucleótidos terapéuticos |
| CN105324119A (zh) * | 2013-06-16 | 2016-02-10 | 国立大学法人东京医科齿科大学 | 具有外显子跳跃效应的双链反义核酸 |
| EP4674963A3 (en) * | 2013-12-09 | 2026-04-29 | Baylor College of Medicine | Hippo and dystrophin complex signaling in cardiomyocyte renewal |
| TWI737736B (zh) * | 2016-05-24 | 2021-09-01 | 美商薩羅塔治療公司 | 製備磷醯二胺嗎啉代寡聚物之方法 |
| US11260134B2 (en) | 2016-09-29 | 2022-03-01 | National University Corporation Tokyo Medical And Dental University | Double-stranded nucleic acid complex having overhang |
| WO2018165541A1 (en) * | 2017-03-10 | 2018-09-13 | The Board Of Regents Of The University Of Texas System | Treatment of fuchs' endothelial corneal dystrophy |
| JP7605577B2 (ja) | 2018-09-19 | 2024-12-24 | 東洋製罐グループホールディングス株式会社 | 二重容器の製造方法 |
-
2021
- 2021-03-12 US US17/906,444 patent/US20230174981A1/en active Pending
- 2021-03-12 WO PCT/JP2021/010214 patent/WO2021187392A1/ja not_active Ceased
- 2021-03-12 JP JP2022508332A patent/JPWO2021187392A1/ja active Pending
- 2021-03-12 EP EP21770458.4A patent/EP4123023A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021187392A5 (https=) | ||
| JPWO2020209285A5 (https=) | ||
| JP2025165976A5 (https=) | ||
| JP5802770B2 (ja) | ｍＲＮＡ前駆体のスプライシングを修飾するＥＮＡ核酸医薬 | |
| JP2015502134A5 (https=) | ||
| US20090186846A1 (en) | Methods to reprogram splice site selection in pre-messenger RNAs | |
| CN102459301A (zh) | 亲脂性多聚核苷酸缀合物 | |
| JPWO2023022229A5 (https=) | ||
| JP2019503394A5 (https=) | ||
| JP2023068035A5 (https=) | ||
| AU2014282666A1 (en) | Double-stranded antisense nucleic acid with exon-skipping effect | |
| CN101448945A (zh) | 用于诱导外显子跳跃的手段和方法 | |
| JP2016513976A5 (https=) | ||
| JP2010528041A5 (https=) | ||
| JP2009514877A5 (https=) | ||
| JP2005529959A (ja) | 細胞へのポリヌクレオチドの伝達をするための新規な方法 | |
| TW202400190A (zh) | 活化補體因子h表現的寡核苷酸調節劑 | |
| JP2019523302A5 (https=) | ||
| HRP20020074A2 (en) | Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes | |
| EP2125029B1 (en) | Construction and use of transfection enhancer elements | |
| Maina et al. | Solid-phase synthesis, characterization and RNAi activity of branch and hyperbranch siRNAs | |
| KR20240040112A (ko) | 방법 | |
| CN119487192A (zh) | 小激活核酸分子及其在治疗遗传性血管性水肿中的用途 | |
| WO2024073589A3 (en) | Compositions and methods for treatment of neuroinflammatory diseases | |
| JPWO2021066931A5 (https=) |